Biotechnology Assets S.A. (BST) — Financial Flexibility Index
Biotechnology Assets S.A. (BST) has a Financial Flexibility Index of 0.09x as of June 2025. Free cash flow of €660.12K (operating CF €658.13K minus capex €1.99K) represents 0% of total liabilities (€7.01 Million). Also explore net asset momentum of Biotechnology Assets S.A. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biotechnology Assets S.A. Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Biotechnology Assets S.A. across 11 annual periods. Check Biotechnology Assets S.A. (BST) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Biotechnology Assets S.A. (2014–2024)
Year-by-year free cash flow to debt coverage for Biotechnology Assets S.A.. For the full company profile including market capitalisation, see BST company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | €646.88K | €-73.85K | €8.17 Million | ▲ +113.4% |
| 2023 | 0.04x | €373.71K | €47.74K | €10.08 Million | ▼ -99.7% |
| 2022 | 14.37x | €209.79 Million | €-1.73 Million | €14.60 Million | ▲ +26655.3% |
| 2021 | -0.05x | €-840.64K | €-1.50 Million | €15.54 Million | ▼ -109.6% |
| 2020 | 0.56x | €9.19 Million | €8.79 Million | €16.37 Million | ▲ +722.1% |
| 2019 | -0.09x | €-7.68 Million | €-15.16 Million | €85.11 Million | ▼ -186.2% |
| 2018 | -0.03x | €-1.83 Million | €-13.02 Million | €58.04 Million | ▼ -116.9% |
| 2017 | 0.19x | €1.78 Million | €213.49K | €9.56 Million | ▼ -75.1% |
| 2016 | 0.75x | €5.98 Million | €2.71 Million | €8.02 Million | ▲ +340.0% |
| 2015 | 0.17x | €1.23 Million | €158.16K | €7.23 Million | ▲ +251.6% |
| 2014 | 0.05x | €338.07K | €-303.79K | €7.01 Million | — |